Drugs Financial Statements From 2010 to 2025

DMAA Stock   10.37  0.01  0.1%   
Drugs Made's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Drugs Made's valuation are provided below:
Market Capitalization
347.6 M
Drugs Made In does not presently have any fundamental signals for analysis.
Check Drugs Made financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Drugs Made's main balance sheet or income statement drivers, such as , as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or Days Sales Outstanding of 0.0. Drugs financial statements analysis is a perfect complement when working with Drugs Made Valuation or Volatility modules.
Check out the analysis of Drugs Made Correlation against competitors.

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Invested Capital3.4 K3.8 K4.1 K
Slightly volatile
Cash Per Share1.0E-41.0E-42.0E-4
Slightly volatile
Net Current Asset Value3.4 K3.8 K4.1 K
Slightly volatile
Income Quality0.50.550.6045
Slightly volatile
ROE1.571.771.9265
Slightly volatile
Current Ratio5.025.656.1555
Slightly volatile
Capex Per Share0.00.00.0
Slightly volatile
Graham Net Net1.0E-41.0E-41.0E-4
Slightly volatile
Interest Debt Per Share1.0E-41.0E-41.0E-4
Slightly volatile
Debt To Assets0.961.081.1796
Slightly volatile
Total Debt To Capitalization1.261.421.5529
Slightly volatile
Return On Capital Employed1.571.761.9199
Slightly volatile
Quick Ratio5.025.656.1555
Slightly volatile
Cash Ratio1.361.531.6663
Slightly volatile
Debt Ratio0.961.081.1796
Slightly volatile
Return On Equity1.571.771.9265
Slightly volatile

Drugs Made Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Working Capital3.4 K3.8 K4.1 K
Slightly volatile
Enterprise Value68.3 M76.8 M83.8 M
Slightly volatile

Drugs Fundamental Market Drivers

Short Percent Float0.0015
Short Percent0.0015

About Drugs Made Financial Statements

Drugs Made stakeholders use historical fundamental indicators, such as Drugs Made's revenue or net income, to determine how well the company is positioned to perform in the future. Although Drugs Made investors may analyze each financial statement separately, they are all interrelated. For example, changes in Drugs Made's assets and liabilities are reflected in the revenues and expenses on Drugs Made's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Drugs Made In. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Drugs Made In is a strong investment it is important to analyze Drugs Made's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Drugs Made's future performance. For an informed investment choice regarding Drugs Stock, refer to the following important reports:
Check out the analysis of Drugs Made Correlation against competitors.
You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Is Diversified Capital Markets space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Drugs Made. If investors know Drugs will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Drugs Made listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Drugs Made In is measured differently than its book value, which is the value of Drugs that is recorded on the company's balance sheet. Investors also form their own opinion of Drugs Made's value that differs from its market value or its book value, called intrinsic value, which is Drugs Made's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Drugs Made's market value can be influenced by many factors that don't directly affect Drugs Made's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Drugs Made's value and its price as these two are different measures arrived at by different means. Investors typically determine if Drugs Made is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Drugs Made's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.